PMID: 8612640Mar 1, 1996Paper

Regulation of expression of the rat serine protease inhibitor 2.3 gene by glucocorticoids and interleukin-6. A complex and unusual interplay between positive and negative cis-acting elements

European Journal of Biochemistry
A E Simar-BlanchetA Le Cam

Abstract

The rat serine protease inhibitor 2.3 gene (spi 2.3) is almost completely silent in normal animals and is transiently expressed during acute inflammation. It encodes a potential anti-elastase which is likely to play a major physiological role for the host defense. Two well-known inflammatory mediators, glucocorticoids and interleukin-6 (IL-6) activate the spi 2.3 promoter and increase steady-state levels of mRNA in cultured hepatocytes. GC activation is mediated by a single glucocorticoid-response element which seems to act autonomously. A unique array of four functional IL-6-response sites was identified in the spi 2.3 promoter. Three of them (C-II--IV) bear structural identity to the CCAAT/enhancer-binding-protein-binding site consensus sequence, whereas the fourth closely resembles the consensus kappa B nuclear factor recognition motif. The C-IV element, which is the most active, contains the motif 5'-CTGGGA and binds the IL-6-inducible acute-phase response factor present in liver nuclear extracts from inflamed rats. Both basal and IL-6-dependent activities of each individual cytokine-response element tested separately are strongly down regulated by a recently identified regulatory sequence, located in the 3' untranslated re...Continue Reading

References

Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K P LeClairP A Sharp
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S KinoshitaT Kishimoto
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G CourtoisG R Crabtree
Jan 1, 1989·Annals of the New York Academy of Sciences·H BaumannG P Jahreis
Sep 12, 1989·Nucleic Acids Research·V Barbu, F Dautry
Sep 1, 1985·Journal of Steroid Biochemistry·D GagneD Philibert
Jul 11, 1986·Nucleic Acids Research·G PaolellaF Salvatore
Jan 1, 1987·Methods in Enzymology·K B Mullis, F A Faloona
Mar 25, 1983·Nucleic Acids Research·L DenteR Cortese
Aug 1, 1995·European Journal of Biochemistry·A Le Cam, C Legraverend
Mar 1, 1993·Cytokine·D Cosman

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.